Molecular Test for Oncology Drug Seeks Premarket Approval

Article

Roche is seeking FDA premarket approval of its companion diagnostic test for AstraZeneca's investigational therapy for non-small cell lung cancer patients with an acquired resistant mutation.

Roche is seeking FDA premarket approval of its companion diagnostic test for AstraZeneca’s investigational therapy for non-small cell lung cancer (NSCLC) patients with an acquired resistant mutation.

NSCLC patients who have adenocarcinoma with tumor containing an EGFR-sensitizing mutation significantly benefit from existing EGFR TKI therapies. However, about two-thirds of these patients will develop treatment resistance, which is often caused by an acquired mutation called T790M.

Roche’s cobas EGFR Mutation Test v2 is designed to help clinicians identify NSCLC with this T790M mutation who are most likely to benefit from AstraZeneca’s novel AZD9291 therapy, which has been granted Breakthrough Therapy, Orphan Drug, and Fast Track designations from the FDA.

“The collaboration with AstraZeneca to be the companion diagnostic for their third-generation EGFR drug therapy…demonstrates the value of molecular testing in patients,” stated Paul Brown, head of Roche Molecular Diagnostics.

Related Videos
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl - stock.adobe.com
Pharmaceutical manufacture background with glass bottles with clear liquid on automatic conveyor line. | Image Credit: wacomka - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.